Good job
Two people can have the same weight and very different metabolic profiles
Who it tends to work well for: Patients who want a more aggressive approach or who havent responded as well to GLP-1-only treatments
- Submit accurate diagnosis codes (ICD-10) supporting the medical necessity of the drug, corresponding to the patient's condition, such as autoimmune disorders, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohns disease, or ankylosing spondylitis, treated by infliximab-axxq, with proper precautions in cases where it may have adverse outcomes
On the other hand, the California Association of Health Plans said Newsoms proposal should send a strong signal to the Legislature that they should reconsider mandating that health plans cover these costly drugs for weight loss without the proper clinical safeguards in place . California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program
PDA + GHK-Cu protocol: PDA: 500 mcg subcutaneous or oral, once daily GHK-Cu: Per standard dosing guidelines (varies by administration route) Duration: 4 to 8 weeks PDA + SS-31 (Elamipretide) For researchers focused on mitochondrial health and cellular energy, combining penta deca peptide arginate with SS-31 creates a protocol that addresses tissue repair from both structural and energetic perspectives